Neuralstem Signs Agreement With China Medical University

Published:24-June-2009 By Staff Reporter To develop stem cell for stroke treatment in patients Neuralstem has entered into a sponsored research agreement with the China Medical University & Hospital of Taiwan, to prepare for a human clinical trial (using Neuralstem’s human spinal cord neural stem cells) to treat stroke patients. The company said that the therapy will focus on patients whose post-stroke symptoms, including complete or... [read full story]                    

powered by